FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4302424810> ?p ?o ?g. }

• W4302424810 endingPage "103144" @default.
• W4302424810 startingPage "103144" @default.
• W4302424810 abstract "To evaluate the efficacy and safety of photodynamic therapy (PDT) in women with high-risk human papillomavirus (hr-HPV) persistent infection after cervical conization, including loop electrosurgical excision procedure (LEEP) and cold knife conization (CKC).The clinicopathological and follow-up data of 76 women with hr-HPV persistent infection after cervical conization (54 cases with LEEP and 22 cases with CKC) were collected. All the women in this group met these criteria: postoperative pathological diagnosis of LEEP/CKC showed high grade squamous intraepithelial lesions (HSIL) with negative incisal margin, hr-HPV persistent infection after LEEP/CKC ≥ 1 year, colposcopy and histopathology showed no intraepithelial lesions before PDT, and 5-aminolaevulinic acid (5-ALA) as photosensitizer treating for 6 times with an interval of 7-10 days. The above patients were followed up 6 months and 12 months after PDT, and the follow-up contents included Roche Cobas HPV classification test, cytology, colposcopy, and pathological examinations. HPV negative conversion rate is an index to evaluate the efficacy of PDT. In addition, we also assessed the safety of PDT.Six months after PDT, the overall HPV clearance rate was 59.21% (45/76). The HPV negative conversion rates in patients ≤ 50 years old group and > 50 years old group were 68.52% (37/54) and 36.36% (8/22), respectively (P=0.009). But there was no significant difference in HPV clearance rate between the HPV16/18 infection group and other hr-HPV infection group (P=0.3326). 12 months after PDT, 1 case underwent hysterectomy because of progression to HSIL, and 7 cases lost follow-up. The overall HPV clearance rate was 88.24% (60/68). The negative conversion rates of HPV16/18 and other hr-HPV infection groups were 76.00% (19/25) and 95.35% (41/43), respectively (P=0.0458). However, the HPV negative conversion rate was not correlated with the patient's age (P=0.2383). The adverse reactions after PDT were mild, mainly manifested as increased vaginal secretions or burning/tingling.Photodynamic therapy could be an effective treatment for patients with hr-HPV persistent infection after cervical conization and it could promote the negative conversion of hr-HPV and prevent the recurrence progression of cervical intraepithelial neoplasia (CIN) after LEEP/CKC." @default.
• W4302424810 created "2022-10-06" @default.
• W4302424810 creator A5021293751 @default.
• W4302424810 creator A5023492006 @default.
• W4302424810 creator A5037036377 @default.
• W4302424810 creator A5037160914 @default.
• W4302424810 creator A5043094331 @default.
• W4302424810 creator A5043267366 @default.
• W4302424810 creator A5057457203 @default.
• W4302424810 creator A5070830488 @default.
• W4302424810 date "2022-12-01" @default.
• W4302424810 modified "2023-10-17" @default.
• W4302424810 title "Evaluation of the efficacy and safety of 5-aminolevulinic acid-mediated photodynamic therapy in women with high-risk HPV persistent infection after cervical conization" @default.
• W4302424810 cites W1504982954 @default.
• W4302424810 cites W1986535582 @default.
• W4302424810 cites W1990455571 @default.
• W4302424810 cites W2047944451 @default.
• W4302424810 cites W2131255017 @default.
• W4302424810 cites W2158966243 @default.
• W4302424810 cites W2213210908 @default.
• W4302424810 cites W2580399831 @default.
• W4302424810 cites W2861426464 @default.
• W4302424810 cites W2891836094 @default.
• W4302424810 cites W2961592454 @default.
• W4302424810 cites W2972841384 @default.
• W4302424810 cites W2991176945 @default.
• W4302424810 cites W2999125356 @default.
• W4302424810 cites W3083755106 @default.
• W4302424810 cites W3128646645 @default.
• W4302424810 cites W3154718361 @default.
• W4302424810 cites W4225300617 @default.
• W4302424810 cites W4284988122 @default.
• W4302424810 doi "https://doi.org/10.1016/j.pdpdt.2022.103144" @default.
• W4302424810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36210038" @default.
• W4302424810 hasPublicationYear "2022" @default.
• W4302424810 type Work @default.
• W4302424810 citedByCount "4" @default.
• W4302424810 countsByYear W43024248102023 @default.
• W4302424810 crossrefType "journal-article" @default.
• W4302424810 hasAuthorship W4302424810A5021293751 @default.
• W4302424810 hasAuthorship W4302424810A5023492006 @default.
• W4302424810 hasAuthorship W4302424810A5037036377 @default.
• W4302424810 hasAuthorship W4302424810A5037160914 @default.
• W4302424810 hasAuthorship W4302424810A5043094331 @default.
• W4302424810 hasAuthorship W4302424810A5043267366 @default.
• W4302424810 hasAuthorship W4302424810A5057457203 @default.
• W4302424810 hasAuthorship W4302424810A5070830488 @default.
• W4302424810 hasConcept C121608353 @default.
• W4302424810 hasConcept C126322002 @default.
• W4302424810 hasConcept C141071460 @default.
• W4302424810 hasConcept C142724271 @default.
• W4302424810 hasConcept C178790620 @default.
• W4302424810 hasConcept C185592680 @default.
• W4302424810 hasConcept C18823058 @default.
• W4302424810 hasConcept C207886595 @default.
• W4302424810 hasConcept C2776117191 @default.
• W4302424810 hasConcept C2777343196 @default.
• W4302424810 hasConcept C2778220009 @default.
• W4302424810 hasConcept C2778580637 @default.
• W4302424810 hasConcept C2779494336 @default.
• W4302424810 hasConcept C2780742577 @default.
• W4302424810 hasConcept C2781323092 @default.
• W4302424810 hasConcept C29456083 @default.
• W4302424810 hasConcept C2994532551 @default.
• W4302424810 hasConcept C544855455 @default.
• W4302424810 hasConcept C71924100 @default.
• W4302424810 hasConceptScore W4302424810C121608353 @default.
• W4302424810 hasConceptScore W4302424810C126322002 @default.
• W4302424810 hasConceptScore W4302424810C141071460 @default.
• W4302424810 hasConceptScore W4302424810C142724271 @default.
• W4302424810 hasConceptScore W4302424810C178790620 @default.
• W4302424810 hasConceptScore W4302424810C185592680 @default.
• W4302424810 hasConceptScore W4302424810C18823058 @default.
• W4302424810 hasConceptScore W4302424810C207886595 @default.
• W4302424810 hasConceptScore W4302424810C2776117191 @default.
• W4302424810 hasConceptScore W4302424810C2777343196 @default.
• W4302424810 hasConceptScore W4302424810C2778220009 @default.
• W4302424810 hasConceptScore W4302424810C2778580637 @default.
• W4302424810 hasConceptScore W4302424810C2779494336 @default.
• W4302424810 hasConceptScore W4302424810C2780742577 @default.
• W4302424810 hasConceptScore W4302424810C2781323092 @default.
• W4302424810 hasConceptScore W4302424810C29456083 @default.
• W4302424810 hasConceptScore W4302424810C2994532551 @default.
• W4302424810 hasConceptScore W4302424810C544855455 @default.
• W4302424810 hasConceptScore W4302424810C71924100 @default.
• W4302424810 hasLocation W43024248101 @default.
• W4302424810 hasLocation W43024248102 @default.
• W4302424810 hasOpenAccess W4302424810 @default.
• W4302424810 hasPrimaryLocation W43024248101 @default.
• W4302424810 hasRelatedWork W2031135517 @default.
• W4302424810 hasRelatedWork W2083732545 @default.
• W4302424810 hasRelatedWork W2352850374 @default.
• W4302424810 hasRelatedWork W2357160992 @default.
• W4302424810 hasRelatedWork W2373633815 @default.
• W4302424810 hasRelatedWork W2380288792 @default.
• W4302424810 hasRelatedWork W2388674274 @default.
• W4302424810 hasRelatedWork W2392731002 @default.
• W4302424810 hasRelatedWork W2965049737 @default.

• next